Metabolomics

Dataset Information

Gut microbiota ameliorates hepatic fibrosis through modulating intestinal bile acid metabolism and hepatocyte pyroptosis (Hepatic fibrosis feces)


ABSTRACT:

Hepatic fibrosis decreased feces bile acid level. Hepatic fibrosis increased serum bile acid. This result showed that hepatic fibrosis inhibited the excretion of bile acid in clinical patients. This result provided phenotype for hepatic fibrosis patients. Bile acid was important indexes for liver injury. TCDCA was important, and it play toxicity effect through ferroptosis and apoptosis. The research for other bile acid such CA, UDCA, TUDCA, TDCA, LCA, TLCA would be important.


Hepatic fibrosis feces (sample 2) analysis is reported in the current study MTBLS6742.

Hepatic fibrosis serum (sample 1) analysis is reported in MTBLS6732.

Hepatic fibrosis serum+feces (sample 3) analysis is reported in MTBLS6728.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - reverse phase

PROVIDER: MTBLS6742 | MetaboLights | 2023-03-17

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
2_feces_c10_negative.raw Raw
2_feces_c1_negative.raw Raw
2_feces_c2_negative.raw Raw
2_feces_c3_negative.raw Raw
2_feces_c4_negative.raw Raw
Items per page:
1 - 5 of 61
altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets